Bonus Issues

CAPLIN POINT LABORATORIES LTD.

NSE : CAPLIPOINTBSE : 524742ISIN CODE : INE475E01026Industry : Pharmaceuticals & DrugsHouse : Private
BSE1339.35-10.65 (-0.79 %)
PREV CLOSE ( ) 1350.00
OPEN PRICE ( ) 1362.65
BID PRICE (QTY) 1338.20 (13)
OFFER PRICE (QTY) 1341.45 (1)
VOLUME 1605
TODAY'S LOW / HIGH ( )1339.35 1364.70
52 WK LOW / HIGH ( )647.1 1617.8
NSE1345.90-11.25 (-0.83 %)
PREV CLOSE( ) 1357.15
OPEN PRICE ( ) 1361.00
BID PRICE (QTY) 1345.10 (10)
OFFER PRICE (QTY) 1345.90 (114)
VOLUME 9916
TODAY'S LOW / HIGH( ) 1340.50 1364.90
52 WK LOW / HIGH ( )646.8 1619.05

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.